Published in Biochem Biophys Res Commun on December 06, 2002
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron (2008) 2.99
Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron (2006) 2.76
BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol (2007) 2.18
APP processing in Alzheimer's disease. Mol Brain (2011) 2.02
The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener (2007) 1.81
Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron (2008) 1.59
Biology and pathophysiology of the amyloid precursor protein. Mol Neurodegener (2011) 1.58
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.50
Physiological functions of APP family proteins. Cold Spring Harb Perspect Med (2012) 1.44
Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimers Dis (2010) 1.19
Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. Exp Brain Res (2007) 1.12
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging (2006) 1.11
Trafficking regulation of proteins in Alzheimer's disease. Mol Neurodegener (2014) 1.08
Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol Neurodegener (2011) 1.06
Functions of the APP gene family in the nervous system: insights from mouse models. Exp Brain Res (2011) 1.05
Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic Acids Res (2004) 1.05
Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci (2013) 1.05
Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J Biol Chem (2010) 1.05
Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5' untranslated region. Nucleic Acids Res (2007) 1.03
Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production. J Biol Chem (2010) 1.00
Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J (2011) 1.00
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1. J Neurosci (2012) 0.95
Comparative analysis of single and combined APP/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPsα expression. Acta Neuropathol Commun (2014) 0.95
Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. J Biol Chem (2010) 0.94
Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease. J Neurosci (2012) 0.90
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease. Curr Genomics (2007) 0.90
Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex. Eur J Neurosci (2010) 0.89
Alzheimer's secretases regulate voltage-gated sodium channels. Neurosci Lett (2010) 0.89
Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells. PLoS One (2013) 0.87
Identification of BACE1 cleavage sites in human voltage-gated sodium channel beta 2 subunit. Mol Neurodegener (2010) 0.87
The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease. Future Sci OA (2015) 0.86
Regulation of α-secretase ADAM10 expression and activity. Exp Brain Res (2011) 0.85
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes. Front Aging Neurosci (2014) 0.84
BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels. FASEB J (2013) 0.83
Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1. Neurobiol Aging (2008) 0.81
Can BACE1 inhibition mitigate early axonal pathology in neurological diseases? J Alzheimers Dis (2014) 0.80
Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines. Neurobiol Aging (2010) 0.80
BACE1 activity regulates cell surface contactin-2 levels. Mol Neurodegener (2014) 0.80
Surface trafficking of sodium channels in cells and in hippocampal slices. Methods Mol Biol (2011) 0.78
Recessive mutations in COL25A1 are a cause of congenital cranial dysinnervation disorder. Am J Hum Genet (2014) 0.77
Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease. PLoS One (2013) 0.77
Synaptic Cell Adhesion Molecules in Alzheimer's Disease. Neural Plast (2016) 0.76
Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain. EMBO Mol Med (2012) 0.76
A peptide binding to the β-site of APP improves spatial memory and attenuates Aβ burden in Alzheimer's disease transgenic mice. PLoS One (2012) 0.76
Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain. J Biol Chem (2016) 0.75
BACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid. Front Cell Neurosci (2015) 0.75
Structure-activity relationship of memapsin 2: implications on physiological functions and Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai) (2013) 0.75
Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review. Am J Geriatr Psychiatry (2016) 0.75
Splice variants of the Alzheimer's disease beta-secretase, BACE1. Neurogenetics (2012) 0.75
Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1. Neurobiol Aging (2017) 0.75
Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry (2004) 2.09
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Predicting the time of conversion to MCI in the elderly: role of verbal expression and learning. Neurology (2009) 1.54
Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) (2006) 1.48
Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain (2010) 1.37
Resting functional connectivity reveals residual functional activity in Alzheimer's disease. Biol Psychiatry (2013) 1.33
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging (2011) 1.32
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol (2007) 1.26
Targeting nerve growth factor in pain: what is the therapeutic potential? BioDrugs (2008) 1.26
Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem (2009) 1.21
Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol (2009) 1.19
Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging (2005) 1.13
Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol (2005) 1.12
Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet (2003) 1.11
Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis. J Urol (2005) 1.10
Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis (2002) 1.07
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat (2004) 1.06
Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J Neurochem (2008) 1.05
The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett (2011) 1.05
Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay. J Neurosci Methods (2004) 1.04
Herpesviruses in brain and Alzheimer's disease. J Pathol (2002) 1.03
Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging (2005) 0.99
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neurosci Lett (2003) 0.94
Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol (2006) 0.94
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging (2010) 0.93
The effects of galantamine treatment on caregiver time in Alzheimer's disease. Int J Geriatr Psychiatry (2003) 0.92
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflammation (2009) 0.89
Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia. Arterioscler Thromb Vasc Biol (2010) 0.88
The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med Genet (2010) 0.88
Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol (2005) 0.87
Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Hum Genet (2004) 0.87
Clinical utility of computed tomography in the assessment of dementia: a memory clinic study. Int J Geriatr Psychiatry (2004) 0.87
APOE and cerebral amyloid angiopathy in the elderly. Neuroreport (2003) 0.86
Neuroanatomy of impaired self-awareness in Alzheimer's disease and mild cognitive impairment. Cortex (2012) 0.85
Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease. Neurobiol Aging (2012) 0.85
TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiol Aging (2007) 0.84
TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma. J Pharmacol Exp Ther (2005) 0.84
Specific AD impairment in concurrent performance of two memory tasks. Cortex (2007) 0.83
Enhancement of antibody responses to influenza vaccination in the elderly following a cognitive-behavioural stress management intervention. Psychother Psychosom (2003) 0.83
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochem Int (2011) 0.83
A discrete domain of the human TrkB receptor defines the binding sites for BDNF and NT-4. Biochem Biophys Res Commun (2002) 0.82
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. Neurochem Int (2010) 0.82
Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis. Int J Geriatr Psychiatry (2010) 0.82
Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease. Exp Gerontol (2007) 0.81
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. J Neurol (2009) 0.81
Population-based case-control study of white matter changes on brain imaging in transient ischemic attack and ischemic stroke. Stroke (2013) 0.81
Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis. Dement Geriatr Cogn Disord (2003) 0.81
Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling. Stem Cell Res (2013) 0.80
Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project. J Neural Transm (Vienna) (2011) 0.80
APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport (2004) 0.80
Absence of Chlamydia pneumoniae in brain of vascular dementia patients. Neurobiol Aging (2003) 0.79
Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study. Alzheimers Res Ther (2011) 0.79
Bapineuzumab in Alzheimer's disease: where now? Lancet Neurol (2010) 0.78
Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias. J Neurol Sci (2011) 0.78
Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). Alzheimer Dis Assoc Disord (2014) 0.78
Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. Int J Mol Epidemiol Genet (2012) 0.77
Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease. Neurosci Lett (2006) 0.77
Prediction rules for computed tomography in the dementia assessment: do they predict clinical utility of CT? Int J Geriatr Psychiatry (2003) 0.77
Familial Alzheimer's disease presenilin 1 mutation M146V increases gamma secretase cutting of p75NTR in vitro. Brain Res (2007) 0.77
Structural and functional bases of visuospatial associative memory in older adults. Neurobiol Aging (2012) 0.76
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. J Med Chem (2014) 0.75
Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer's disease. J Clin Exp Neuropsychol (2013) 0.75
Galantamine in Alzheimer's disease. Expert Rev Neurother (2008) 0.75
The future of Age and Ageing. Age Ageing (2002) 0.75
Identification of novel small molecule TGF-β antagonists using structure-based drug design. J Comput Aided Mol Des (2013) 0.75